Literature DB >> 18189414

Probing the role of parasite-specific, distant structural regions on communication and catalysis in the bifunctional thymidylate synthase-dihydrofolate reductase from Plasmodium falciparum.

Tina Dasgupta1, Karen S Anderson.   

Abstract

Plasmodium falciparum thymidylate synthase-dihydrofolate reductase (TS-DHFR) is an essential enzyme in nucleotide biosynthesis and a validated molecular drug target in malaria. Because P. falciparum TS and DHFR are highly homologous to their human counterparts, existing active-site antifolate drugs can have dose-limiting toxicities. In humans, TS and DHFR are two separate proteins. In P. falciparum, however, TS-DHFR is bifunctional, with both TS and DHFR active sites on a single polypeptide chain of the enzyme. Consequently, P. falciparum TS-DHFR contains unique distant or nonactive regions that might modulate catalysis: (1) an N-terminal tail and (2) a linker region tethering DHFR to TS, and encoding a crossover helix that forms critical electrostatic interactions with the DHFR active site. The role of these nonactive sites in the bifunctional P. falciparum TS-DHFR is unknown. We report the first in-depth, pre-steady-state kinetic characterization of the full-length, wild-type (WT) P. falciparum TS-DHFR enzyme and probe the role of distant, nonactive regions through mutational analysis. We show that the overall rate-limiting step in the WT P. falciparum TS-DHFR enzyme is TS catalysis. We further show that if TS is in an activated (liganded) conformation, the DHFR rate is 2-fold activated, from 60 s-1 to 130 s-1 in the WT enzyme. The TS rate is also reciprocally activated by approximately 1.5-fold if DHFR is in an activated, ligand-bound conformation. Mutations to the linker region affect neither catalytic rate nor domain-domain communication. Deletion of the N-terminal tail, although in a location remote from the active site, decreases the DHFR single rate and the bifunctional TS-DHFR rate by a factor of 2. The 2-fold activation of the DHFR rate by TS ligands remains intact, although even the activated N-terminal mutant has just half the DHFR activity of the WT enzyme. However, the reciprocal communication between TS active site and DHFR ligands is impaired in N-terminal mutants. Surprisingly, deletion of the analogous N-terminal tail in Leishmania major TS-DHFR causes a 3-fold enhancement of the DHFR rate from approximately 14 s-1 to approximately 40 s-1. In summary, our results demonstrate a complex interplay of domain-domain communication and nonactive-site modulation of catalysis in P. falciparum TS-DHFR. Furthermore, each parasitic TS-DHFR is activated by unique mechanisms, modulated by their nonactive site regions. Finally, our studies suggest the N-terminal tail of P. falciparum TS-DHFR is a highly selective, novel target for potential antifolate development in malaria.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18189414      PMCID: PMC2658879          DOI: 10.1021/bi701624u

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  33 in total

1.  Essential protein-protein interactions between Plasmodium falciparum thymidylate synthase and dihydrofolate reductase domains.

Authors:  S Shallom; K Zhang; L Jiang; P K Rathod
Journal:  J Biol Chem       Date:  1999-12-31       Impact factor: 5.157

2.  Insights into antifolate resistance from malarial DHFR-TS structures.

Authors:  Jirundon Yuvaniyama; Penchit Chitnumsub; Sumalee Kamchonwongpaisan; Jarunee Vanichtanankul; Worachart Sirawaraporn; Paul Taylor; Malcolm D Walkinshaw; Yongyuth Yuthavong
Journal:  Nat Struct Biol       Date:  2003-05

3.  The crystal structure of dihydrofolate reductase-thymidylate synthase from Cryptosporidium hominis reveals a novel architecture for the bifunctional enzyme.

Authors:  Robert H O'Neil; Ryan H Lilien; Bruce R Donald; Robert M Stroud; Amy C Anderson
Journal:  J Eukaryot Microbiol       Date:  2003       Impact factor: 3.346

4.  Effect of N-terminal truncation of Plasmodium falciparum dihydrofolate reductase on dihydrofolate reductase and thymidylate synthase activity.

Authors:  Jantanee Wattanarangsan; Sudsanguan Chusacultanachai; Jirundon Yuvaniyama; Sumalee Kamchonwongpaisan; Yongyuth Yuthavong
Journal:  Mol Biochem Parasitol       Date:  2003-01       Impact factor: 1.759

5.  A major role for a set of non-active site mutations in the development of HIV-1 protease drug resistance.

Authors:  Salman Muzammil; Patrick Ross; Ernesto Freire
Journal:  Biochemistry       Date:  2003-01-28       Impact factor: 3.162

6.  Phylogenetic classification of protozoa based on the structure of the linker domain in the bifunctional enzyme, dihydrofolate reductase-thymidylate synthase.

Authors:  Robert H O'Neil; Ryan H Lilien; Bruce R Donald; Robert M Stroud; Amy C Anderson
Journal:  J Biol Chem       Date:  2003-10-09       Impact factor: 5.157

7.  Correlated motion and the effect of distal mutations in dihydrofolate reductase.

Authors:  Thomas H Rod; Jennifer L Radkiewicz; Charles L Brooks
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-19       Impact factor: 11.205

8.  Kinetic characterization of bifunctional thymidylate synthase-dihydrofolate reductase (TS-DHFR) from Cryptosporidium hominis: a paradigm shift for ts activity and channeling behavior.

Authors:  Chloé E Atreya; Karen S Anderson
Journal:  J Biol Chem       Date:  2004-02-12       Impact factor: 5.157

9.  Nonconserved residues Ala287 and Ser290 of the Cryptosporidium hominis thymidylate synthase domain facilitate its rapid rate of catalysis.

Authors:  Lanxuan T Doan; W Edward Martucci; Melissa A Vargo; Chloé E Atreya; Karen S Anderson
Journal:  Biochemistry       Date:  2007-06-20       Impact factor: 3.162

10.  Characterization, crystallization and preliminary X-ray analysis of bifunctional dihydrofolate reductase-thymidylate synthase from Plasmodium falciparum.

Authors:  Penchit Chitnumsub; Jirundon Yuvaniyama; Jirundon Yavaniyama; Jarunee Vanichtanankul; Sumalee Kamchonwongpaisan; Malcolm D Walkinshaw; Yongyuth Yuthavong
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2004-03-23
View more
  9 in total

1.  Disruption of the crossover helix impairs dihydrofolate reductase activity in the bifunctional enzyme TS-DHFR from Cryptosporidium hominis.

Authors:  Melissa A Vargo; W Edward Martucci; Karen S Anderson
Journal:  Biochem J       Date:  2009-02-01       Impact factor: 3.857

Review 2.  Purine and pyrimidine pathways as targets in Plasmodium falciparum.

Authors:  María Belén Cassera; Yong Zhang; Keith Z Hazleton; Vern L Schramm
Journal:  Curr Top Med Chem       Date:  2011       Impact factor: 3.295

3.  First three-dimensional structure of Toxoplasma gondii thymidylate synthase-dihydrofolate reductase: insights for catalysis, interdomain interactions, and substrate channeling.

Authors:  Hitesh Sharma; Mark J Landau; Melissa A Vargo; Krasimir A Spasov; Karen S Anderson
Journal:  Biochemistry       Date:  2013-10-03       Impact factor: 3.162

4.  Exploring novel strategies for AIDS protozoal pathogens: α-helix mimetics targeting a key allosteric protein-protein interaction in C. hominis TS-DHFR.

Authors:  W Edward Martucci; Johanna M Rodriguez; Melissa A Vargo; Matthew Marr; Andrew D Hamilton; Karen S Anderson
Journal:  Medchemcomm       Date:  2013-09       Impact factor: 3.597

5.  Exploiting structural analysis, in silico screening, and serendipity to identify novel inhibitors of drug-resistant falciparum malaria.

Authors:  Tina Dasgupta; Penchit Chitnumsub; Sumalee Kamchonwongpaisan; Cherdsak Maneeruttanarungroj; Sara E Nichols; Theresa M Lyons; Julian Tirado-Rives; William L Jorgensen; Yongyuth Yuthavong; Karen S Anderson
Journal:  ACS Chem Biol       Date:  2009-01-16       Impact factor: 5.100

6.  Selective peptide inhibitors of bifunctional thymidylate synthase-dihydrofolate reductase from Toxoplasma gondii provide insights into domain-domain communication and allosteric regulation.

Authors:  Mark J Landau; Hitesh Sharma; Karen S Anderson
Journal:  Protein Sci       Date:  2013-08-01       Impact factor: 6.725

7.  Interactions between cycloguanil derivatives and wild type and resistance-associated mutant Plasmodium falciparum dihydrofolate reductases.

Authors:  Phornphimon Maitarad; Sumalee Kamchonwongpaisan; Jarunee Vanichtanankul; Tirayut Vilaivan; Yongyuth Yuthavong; Supa Hannongbua
Journal:  J Comput Aided Mol Des       Date:  2009-01-21       Impact factor: 3.686

8.  Insights into the role of the junctional region of Plasmodium falciparum dihydrofolate reductase-thymidylate synthase.

Authors:  Natpasit Chaianantakul; Rachada Sirawaraporn; Worachart Sirawaraporn
Journal:  Malar J       Date:  2013-03-12       Impact factor: 2.979

9.  Multiple origins and regional dispersal of resistant dhps in African Plasmodium falciparum malaria.

Authors:  Richard J Pearce; Hirva Pota; Marie-Solange B Evehe; El-Hadj Bâ; Ghyslain Mombo-Ngoma; Allen L Malisa; Rosalynn Ord; Walter Inojosa; Alexandre Matondo; Diadier A Diallo; Wilfred Mbacham; Ingrid V van den Broek; Todd D Swarthout; Asefaw Getachew; Seyoum Dejene; Martin P Grobusch; Fanta Njie; Samuel Dunyo; Margaret Kweku; Seth Owusu-Agyei; Daniel Chandramohan; Maryline Bonnet; Jean-Paul Guthmann; Sian Clarke; Karen I Barnes; Elizabeth Streat; Stark T Katokele; Petrina Uusiku; Chris O Agboghoroma; Olufunmilayo Y Elegba; Badara Cissé; Ishraga E A-Elbasit; Hayder A Giha; S Patrick Kachur; Caroline Lynch; John B Rwakimari; Pascalina Chanda; Moonga Hawela; Brian Sharp; Inbarani Naidoo; Cally Roper
Journal:  PLoS Med       Date:  2009-04-14       Impact factor: 11.069

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.